Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Anthony Rizzo, MD, is a Staff Surgeon in the Department of Vascular Surgery at the Cleveland Clinic’s Hillcrest Hospital in Mayfield Heights, Ohio. Prior to his Clinic appointment in 2002, he was a private-practice vascular surgeon at Christus Schumpert Medical Center in Shreveport, La., and a general surgeon with Surgical Associates of Eastern Shore in Fairhope, Ala. His specialties include carotid-artery surgery and thoracic aortic aneurysm repair and reconstruction.
Dr. Rizzo received his medical degree from Temple University Medical School, Philadelphia, after earning a bachelor of science degree from Allegheny College in Meadville, Pa. He completed his surgical internship at the university of Pennsylvania Graduate Hospital and was a surgical resident at Temple University Hospital and the University of South Alabama, Mobile, Ala. He also completed a research fellowship at the University of South Alabama and a vascular-surgery fellowship at the Cleveland Clinic. He is board-certified in general and vascular surgery by the American Board of Surgery.
He has served as a lecturer and presenter at medical conferences nationwide. He has authored chapters for two books--Reperfusion Injuries and Clinical Capillary Leak Syndrome, published in 1994, and Interstitium, Connective tissue and Lymphatics (1995) – and has co-authored numerous articles that have been published in leading medical journals such as the American Journal of Physiology, American Surgeon, Respiratory and Critical Care Medicine and the Journal of Vascular Surgery.
Aortic aneurysms, carotid artery disease, peripheral artery disease, aorta surgery, carotid endarterectomy, carotid stenting, dialysis access procedures, stents for peripheral vascular disease, surgery for peripheral arterial disease (PAD), aortic aneurysm open repair and endovascular repair
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Rizzo's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.